Search results
Author(s):
Fouad Khalil
,
Konstantinos C Siontis
,
Gabor Bagameri
,
et al
Added:
3 years ago
Catheter-based ablation has been a well-established tool in the treatment of ventricular tachycardia (VT). However, the effectiveness of catheter ablation may be limited by its ability to access sites of arrhythmogenic tissue and achieve adequate lesion size in target areas without risking collateral damage. Antiarrhythmic surgery would be an effective alternative in such situations. Despite the…
View more
Author(s):
Amit J Thosani
,
Paul Gerczuk
,
Emerson Liu
,
et al
Added:
3 years ago
Atrial fibrillation (AF) is the most common cardiac arrhythmia worldwide. In 2010, the prevalence of AF in the US was estimated at 5.9 million.1 The decision to pursue treatment to maintain sinus rhythm is driven by disabling symptoms related to AF; including palpitations, dyspnoea, fatigue, stroke and congestive heart failure. Percutaneous catheter-based ablation is an established therapy for…
View more
Author(s):
George D Katritsis
,
Demosthenes G Katritsis
Added:
3 years ago
Implantable cardiac devices, such as pacemakers, are used to treat a number of heart conditions, especially those related to the electrical conduction system. Cardiac pacemakers are a well-established and effective therapy, and have been in use for more than 50 years.
The first pacemaker was implanted in a patient in October 1958 by Åke Senning in Stockholm, in cooperation with engineer Rune…
View more
Author(s):
Riyaz Kaba
,
Omar Ahmed
,
Elijah R Behr
,
et al
Added:
1 year ago
Author(s):
Jonathan S Steinberg
,
David Slotwiner
Added:
3 years ago
Electrical Remodelling
Evidence Supporting Atrial Remodelling
The concept of electrical remodelling was first introduced in 1995 simultaneously by Wijffels et al.1 and Morillo et al.2 who demonstrated that once sustained atrial fibrillation (AF) was induced in goats, or rapid atrial pacing was performed in dogs, physiological changes occurred that favoured the maintenance of AF.3 This led to the…
View more
Author(s):
Ramanan Kumareswaran
,
Francis E Marchlinski
Added:
3 years ago
Ventricular tachycardia (VT) is one of the most challenging medical conditions faced by cardiac patients and physicians treating them. Antiarrhythmic medications have limited effectiveness and are frequently poorly tolerated.1–4 Catheter ablation is increasingly used to treat patients successfully.1,5–7 Most VTs can be ablated endocardially but some require epicardial mapping and ablation…
View more
ACC 2023: Late-Breaking Science Video Collection
Author(s):
Enoch Akowuah
,
Annapoorna Kini
,
Atul Verma
,
et al
Added:
1 year ago
Video Series
Author(s):
Marco V Mariani
,
Agostino Piro
,
Domenico G Della Rocca
,
et al
Added:
2 years ago
Author(s):
Megan Barber
,
Jason Chinitz
,
Roy John
Added:
3 years ago
Ventricular arrhythmias are designated idiopathic when demonstrable structural heart disease, significant coronary disease including coronary spasm or genetic arrhythmia syndromes are absent.1 These arrhythmias may be benign but are also a recognised cause of sudden cardiac death. The common form of idiopathic ventricular tachycardia (VT) originates in the ventricular outflow tracts, manifest…
View more
Author(s):
Takumi Yamada
,
G Neal Kay
Added:
3 years ago
Idiopathic ventricular arrhythmias (IVAs) usually originate from the specific anatomical structures. For the past decade, major IVA origins from both endocardial and epicardial sites have been increasingly recognised (see Table 1).1–3 Catheter ablation of IVAs is usually safe and highly successful, but can sometimes be challenging because of the anatomical obstacles. Therefore, understanding the…
View more